HJLIWのニュース
Hancock Jaffe To Rebrand As enVVeno Medical 2021/09/22 11:09:30 Benzinga
Full story available on Benzinga.com
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs 2021/09/21 20:08:00 FinanzNachrichten
- Hancock Jaffe changing name to enVVeno Medical Corporation and ticker symbol to NASDAQ: NVNO, effective October 1, 2021 -- Development strategy to focus on venous disease and advancement of the V
Breathtaking stocks: MannKind Corporation (NASDAQ:MNKD -1.54%), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI 3.14%) 2021/09/17 23:51:31 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Breathtaking stocks: MannKind Corporation (NASDAQ:MNKD -1.54%), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI 3.14%) appeared first on Stocks Equity .
Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics 2021/09/08 23:43:33 Seeking Alpha
Hancock Jaffe Laboratories < > presents at HealthVirtual Conference - slideshow 2021/07/16 20:01:09 Seeking Alpha
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference 2021/07/08 13:08:00 FinanzNachrichten
Live webcast on Tuesday, July 13th at 1:00 PM ETIRVINE, CA / ACCESSWIRE / July 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a developer of medical de
Up to Date Trending Stock: Delta Air Lines, Inc. (NYSE:DAL), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) 2021/07/08 02:06:11 Stock Equity
Delta Air Lines, Inc. (NYSE:DAL) with the stream of -1.06% also noticed, India Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) encountered a rapid change of -3.85% in the last hour of Wednesday’s … The post Up to Date Trending Stock: Delta Air Lines, Inc. (NYSE:DAL), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) appeared first on Stocks Equity .